Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a ...

A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

Psilocybin, a psychedelic compound once primarily known as a party drug, is increasingly being recognised for its medical ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can ...

New Zealand today approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called “magic ...

New results from a clinical trial reveal that a single dose of psilocybin-a naturally occurring psychedelic compound found in ...